Pill Identifier App

Pharmaceutical Sales 2008

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2008, listed by U.S. sales value and brand name.
New: Quarterly Top 100 prescription sales data now available, from Q1 2011 more....

Top 200 Drugs for 2008 by Sales

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2007
1 Lipitor Pfizer Inc 5,880,128 -4.6%
2 Nexium AstraZeneca Pharmaceuticals, LP 4,794,450 10.1%
3 (2) Plavix Bristol-Myers Squibb Company 3,796,221 23.1%
4 (1) Advair Diskus GlaxoSmithKline 3,572,473 5.4%
5 (1) Prevacid Takeda Pharmaceuticals U.S.A., Inc 3,295,465 -0.6%
6 (1) Seroquel AstraZeneca Pharmaceuticals, LP 2,908,971 15.5%
7 (1) Singulair Merck & Co., Inc. 2,898,060 1.2%
8 Effexor XR Pfizer Inc 2,657,729 7.8%
9 (24) OxyContin Purdue Pharma LP 2,502,982 139.8%
10 Actos Takeda Pharmaceuticals U.S.A., Inc 2,447,602 9.8%
11 (2) Lexapro Forest Pharmaceuticals, Inc 2,412,048 4.7%
12 (3) Abilify Bristol-Myers Squibb Company 2,371,795 33.1%
13 Topamax Janssen Pharmaceuticals, Inc 2,177,348 18.5%
14 (2) Cymbalta Eli Lilly and Company 2,170,162 25.2%
15 (3) Zyprexa Eli Lilly and Company 1,748,259 10.7%
16 (6) Valtrex GlaxoSmithKline 1,684,192 20.7%
17 (6) Crestor AstraZeneca Pharmaceuticals, LP 1,676,553 22.6%
18 (6) Vytorin Merck & Co., Inc. 1,545,643 -20.3%
19 (2) Lamictal GlaxoSmithKline 1,539,101 -10.4%
20 Celebrex Pfizer Inc 1,526,818 7.8%
21 (5) Lantus Sanofi (formerly Sanofi Aventis) 1,475,110 13.2%
22 (3) Levaquin Janssen Pharmaceuticals, Inc 1,461,080 2.0%
23 (4) Adderall XR Shire US Inc 1,446,629 12.2%
24 (13) Lyrica Pfizer Inc 1,389,205 38.9%
25 (3) Diovan Novartis Corporation 1,283,141 14.8%
26 (4) Tricor Abbott Laboratories 1,249,299 12.9%
27 (9) Flomax Boehringer Ingelheim Pharmaceuticals, Inc 1,236,963 23.4%
28 (14) Risperdal Janssen Pharmaceuticals, Inc 1,221,505 -31.8%
29 (3) Diovan HCT Novartis Corporation 1,212,308 15.3%
30 (9) Zetia Merck & Co., Inc. 1,183,627 -15.8%
31 (8) Aricept Eisai Corporation 1,149,221 16.9%
32 (15) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc 1,142,746 31.6%
33 (1) Concerta Johnson & Johnson 1,103,973 7.1%
34 (3) Aciphex Eisai Corporation 1,052,133 -4.3%
35 (5) Imitrex Oral GlaxoSmithKline 972,778 2.3%
36 (13) Lidoderm Endo Pharmaceuticals 970,208 20.1%
37 (20) Keppra UCB Inc. 940,941 32.8%
38 (10) Viagra Pfizer Inc 920,051 11.5%
39 (22) Atripla Gilead Sciences, Inc. 915,561 48.3%
40 (13) Lovenox Sanofi (formerly Sanofi Aventis) 913,764 22.5%
41 (43) Januvia Merck & Co., Inc. 913,501 93.7%
42 (1) Nasonex Merck & Co., Inc. 904,074 1.3%
43 (2) Ambien CR Sanofi (formerly Sanofi Aventis) 865,719 -1.2%
44 (10) Provigil Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd) 846,089 13.6%
45 (13) Geodon Oral Pfizer Inc 797,100 19.9%
46 (16) Truvada Gilead Sciences, Inc. 775,787 28.0%
47 (8) Lunesta Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 771,019 8.2%
48 (2) Enbrel Amgen Inc. 763,927 -12.7%
49 (1) Actonel Actavis (acquired Watson & Warner Chilcott) 714,977 -9.6%
50 (13) CellCept Roche Pharmaceuticals 711,530 18.7%
51 (14) Humalog Eli Lilly and Company 702,798 18.7%
52 (8) Detrol LA Pfizer Inc 696,934 9.6%
53 (13) Depakote ER Abbott Laboratories 692,472 20.0%
54 (5) Cozaar Merck & Co., Inc. 690,028 5.8%
55 (9) Pulmicort Respules AstraZeneca Pharmaceuticals, LP 651,024 9.9%
56 (14) Niaspan Abbott Laboratories 638,816 16.9%
57 (19) Wellbutrin XL Valeant Pharmaceuticals International 613,694 -38.2%
58 (7) Chantix Pfizer Inc 605,323 -20.8%
59 (13) Budeprion XL Teva Pharmaceuticals 595,206 10.8%
60 (11) Byetta Amylin Pharmaceuticals, Inc. 594,736 9.9%
61 (69) Yaz Bayer Healthcare Pharmaceuticals 585,421 129.9%
62 (17) Prograf Astellas Pharma US 584,703 13.3%
63 (20) Namenda Forest Pharmaceuticals, Inc 582,468 18.9%
64 (16) Arimidex AstraZeneca Pharmaceuticals, LP 568,846 12.3%
65 (9) Combivent Boehringer Ingelheim Pharmaceuticals, Inc 558,351 4.6%
66 (20) Cialis Eli Lilly and Company 555,080 22.5%
67 (10) Flovent HFA GlaxoSmithKline 553,050 6.1%
68 (57) Protonix Wyeth 552,903 -74.1%
69 (1) Premarin Tabs Wyeth 548,917 -1.5%
70 (50) Suboxone Reckitt Benckiser Pharmaceuticals Inc. 531,808 88.4%
71 (11) Hyzaar Merck & Co., Inc. 528,401 5.7%
72 (19) ProAir HFA Teva Pharmaceuticals 527,655 25.3%
73 (14) Reyataz Bristol-Myers Squibb Company 519,398 18.4%
74 (19) Benicar HCT Daiichi Sankyo 515,213 24.4%
75 (6) Synthroid Abbott Laboratories 514,887 -6.0%
76 (47) Avandia GlaxoSmithKline 513,715 -53.7%
77 (19) Boniva Genentech, Inc (member of Roche group) 512,179 26.7%
78 (5) Strattera Eli Lilly and Company 511,612 -4.5%
79 () Polymagma Plain 507,096 NA
80 (2) Skelaxin Elan Corporation 501,310 -3.1%
81 Evista Eli Lilly and Company 499,924 -0.7%
82 (10) Asacol Procter & Gamble 463,747 10.2%
83 (16) Depakote Abbott Laboratories 456,909 -20.4%
84 (4) Xalatan Pfizer Inc 456,321 5.9%
85 Humira Abbott Laboratories 455,911 -1.4%
86 (16) Benicar Daiichi Sankyo 455,408 23.2%
87 (12) Gleevec Novartis Corporation 450,576 17.2%
88 (15) AndroGel Abbott Laboratories 441,168 20.5%
89 (26) Enbrel Sureclick Amgen Inc. 433,792 47.9%
90 Avelox Bayer Healthcare Pharmaceuticals 428,793 1.0%
91 (3) Fentanyl Oral Citrate 423,743 3.8%
92 (39) Lovaza GlaxoSmithKline 417,542 65.2%
93 (20) RenaGel Genzyme Corporation 408,552 39.2%
94 (4) Avapro Bristol-Myers Squibb Company 405,557 5.4%
95 (67) Humira Pen Abbott Laboratories 381,397 99.4%
96 () Vyvanse Shire US Inc 374,990 486.1%
97 (3) Kaletra Abbott Laboratories 373,122 0.0%
98 (6) Xopenex Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 371,995 4.9%
99 (13) Copaxone Sanofi (formerly Sanofi Aventis) 370,479 22.1%
100 (21) Avodart GlaxoSmithKline 364,706 29.6%
101 (13) Femara Novartis Corporation 360,993 23.0%
102 (5) Avalide Bristol-Myers Squibb Company 355,748 8.2%
103 (2) Ortho Tri-Cyclen Lo Ortho-McNeil-Janssen Pharmaceuticals, Inc. 350,375 -5.7%
104 (23) Sensipar Amgen Inc. 348,365 30.8%
105 (13) Aldara Medicis Pharmaceutical Corporation 347,587 20.9%
106 (10) NovoLog Mix 70/30 Novo Nordisk, Inc. 347,106 18.7%
107 (18) Restasis Allergan, Inc 339,110 23.4%
108 (24) Mirapex Boehringer Ingelheim Pharmaceuticals, Inc 335,293 34.2%
109 (33) Yasmin 28 Bayer Healthcare Pharmaceuticals 328,905 -37.7%
110 (33) Solodyn Medicis Pharmaceutical Corporation 316,079 40.8%
111 () Lantus SoloSTAR Sanofi (formerly Sanofi Aventis) 315,946 829.5%
112 (11) Norvir Abbott Laboratories 311,245 13.1%
113 (20) Focalin XR Novartis Corporation 310,010 24.5%
114 (26) Actoplus Met Takeda Pharmaceuticals U.S.A., Inc 301,258 31.1%
115 (37) Vesicare Astellas Pharma US 299,147 45.5%
116 (3) Forteo Eli Lilly and Company 291,621 3.3%
117 (7) Allegra-D 12 Hour Sanofi (formerly Sanofi Aventis) 288,202 -9.0%
118 (13) Procrit Centocor Ortho Biotech, Inc 287,898 -18.5%
119 (11) Nasacort AQ Sanofi (formerly Sanofi Aventis) 285,359 -10.4%
120 (8) Tarceva Astellas Pharma US 276,875 4.9%
121 (12) Combivir GlaxoSmithKline 275,844 -13.3%
122 () Tamiflu Genentech, Inc (member of Roche group) 275,121 138.3%
123 (3) Avonex Biogen Idec 273,303 2.4%
124 (13) NuvaRing Merck & Co., Inc. 267,259 15.9%
125 (74) Coreg CR GlaxoSmithKline 265,844 83.5%
126 (10) Epzicom GlaxoSmithKline 265,252 15.0%
127 () Levemir Novo Nordisk, Inc. 256,142 103.5%
128 (17) Duragesic Johnson & Johnson 251,699 -17.8%
129 (31) Risperdal Consta Janssen Pharmaceuticals, Inc 250,948 29.5%
130 (5) Zyvox Pfizer Inc 249,712 5.6%
131 (36) Tussionex Sanofi (formerly Sanofi Aventis) 246,583 37.5%
132 () Invega Janssen Pharmaceuticals, Inc 246,052 146.4%
133 (109) Fosamax Merck & Co., Inc. 244,850 -81.9%
134 (29) Kadian Actavis (acquired Watson & Warner Chilcott) 244,504 27.9%
135 (23) Levitra Bayer Healthcare Pharmaceuticals 239,860 21.4%
136 (28) Differin Galderma Laboratories 239,747 27.4%
137 (9) Astelin Meda Pharmaceuticals 239,404 9.1%
138 (3) Lumigan Allergan, Inc 238,436 5.1%
139 () Symbicort AstraZeneca Pharmaceuticals, LP 237,955 683.9%
140 () Janumet Merck & Co., Inc. 237,426 379.2%
141 (15) Xeloda Genentech, Inc (member of Roche group) 236,302 17.3%
142 (25) Clarinex Merck & Co., Inc. 233,417 -19.2%
143 () Proventil HFA Merck & Co., Inc. 227,833 66.4%
144 (9) Humalog Mix 75/25 Pn 226,996 11.1%
145 (2) BenzaClin Sanofi (formerly Sanofi Aventis) 225,984 6.0%
146 (5) Vigamox Alcon Laboratories, Inc. 220,720 6.6%
147 (8) Fosamax Plus D Merck & Co., Inc. 218,738 -4.9%
148 (21) Maxalt Merck & Co., Inc. 218,686 23.7%
149 (15) Cosopt Merck & Co., Inc. 218,315 -10.1%
150 (55) Requip GlaxoSmithKline 213,127 -47.7%
151 (3) Relpax Pfizer Inc 213,123 0.3%
152 (23) Patanol Alcon Laboratories, Inc. 211,608 -18.2%
153 (3) Casodex AstraZeneca Pharmaceuticals, LP 210,830 1.6%
154 (22) Welchol Daiichi Sankyo 209,309 29.4%
155 (17) Ciprodex Otic Alcon Laboratories, Inc. 207,845 19.3%
156 (7) Viread Gilead Sciences, Inc. 207,458 -1.6%
157 (8) Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc 204,665 9.2%
158 () Loestrin 24 Fe Teva Pharmaceuticals 200,272 42.0%
159 (15) Thalomid Celgene Corporation 198,528 -10.9%
160 (6) Alphagan P Allergan, Inc 195,794 5.2%
161 (2) Endocet Endo Pharmaceuticals 194,559 0.3%
162 () Revlimid Celgene Corporation 194,505 99.8%
163 (39) Avandamet GlaxoSmithKline 192,785 -29.9%
164 (13) Maxalt MLT 192,378 19.0%
165 (109) Altace King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 191,053 -73.1%
166 (11) Budeprion SR Teva Pharmaceuticals 188,956 -6.2%
167 (16) Pegasys Genentech, Inc (member of Roche group) 188,011 20.5%
168 (16) Ultram ER Ortho-McNeil-Janssen Pharmaceuticals, Inc. 185,318 19.2%
169 (25) Fentora Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd) 185,244 25.6%
170 (8) Asmanex Merck & Co., Inc. 185,244 14.9%
171 (29) Rhinocort Aqua AstraZeneca Pharmaceuticals, LP 184,397 -18.3%
172 (1) Temodar Merck & Co., Inc. 183,005 5.5%
173 (18) Micardis HCT Abbott Laboratories 180,407 21.8%
174 () Sotret Ranbaxy Pharmaceuticals Inc. 176,782 35.3%
175 (21) Trizivir GlaxoSmithKline 176,538 -13.1%
176 (19) Enablex Warner Chilcott 176,293 19.6%
177 () Isentress Merck & Co., Inc. 175,457 >999
178 (4) Tobradex Alcon Laboratories, Inc. 175,251 1.4%
179 (104) Trileptal Novartis Corporation 170,422 -68.0%
180 (23) Sustiva Bristol-Myers Squibb Company 169,984 -15.0%
181 () Amitiza Takeda Pharmaceuticals U.S.A., Inc 169,610 41.3%
182 () Micardis Boehringer Ingelheim Pharmaceuticals, Inc 165,979 18.7%
183 (3) Zovirax Topical GlaxoSmithKline 164,974 8.6%
184 () Ocella Teva Pharmaceuticals 164,399 NA
185 () Propecia Merck & Co., Inc. 163,166 13.7%
186 () Taclonex Warner Chilcott 161,674 23.4%
187 (49) Actiq Abbott Laboratories 161,532 -29.8%
188 () Valcyte Roche Pharmaceuticals 160,605 15.3%
189 (7) Klor-Con Upsher-Smith Laboratories Inc. 159,584 0.2%
190 (11) Atacand AstraZeneca Pharmaceuticals, LP 159,583 -0.7%
191 () Doryx Pfizer Inc 158,466 20.4%
192 () Veramyst GlaxoSmithKline 158,347 289.8%
193 (4) Avinza King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 157,224 7.9%
194 (1) Allegra-D 24 Hour Sanofi (formerly Sanofi Aventis) 156,445 5.7%
195 () Opana ER Endo Pharmaceuticals 155,662 126.7%
196 () Zomig AstraZeneca Pharmaceuticals, LP 153,913 6.7%
197 () Humulin 70/30 Eli Lilly and Company 153,026 7.2%
198 Prempro Pfizer Inc 152,633 5.4%
199 (9) Humulin N Eli Lilly and Company 152,147 1.5%
200 () Xopenex HFA Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 151,919 25.8%
All Others 26,307,000 -15.0%

Source: Verispan, VONA

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Hide
(web5)